153 related articles for article (PubMed ID: 30402386)
41. [Diagnosis of malignant pleural mesothelioma--thoracoscopic biopsy and tumor marker].
Suzuki K
Nihon Geka Gakkai Zasshi; 2009 Nov; 110(6):333-7. PubMed ID: 19999567
[TBL] [Abstract][Full Text] [Related]
42. Analysis of early pleural fluid samples in patients with mesothelioma: A case series exploration of morphology, BAP1, and CDKN2A status with implications for the concept of mesothelioma in situ in cytology.
Louw A; van Vliet C; Peverall J; Colkers S; Acott N; Creaney J; Lee YCG; Chai SM
Cancer Cytopathol; 2022 May; 130(5):352-362. PubMed ID: 35143119
[TBL] [Abstract][Full Text] [Related]
43. Epithelioid pleural mesothelioma concurrently associated with miliary pulmonary metastases and minimal change nephrotic syndrome - A hitherto undescribed case.
Tsukamoto Y; Otsuki T; Hao H; Kuribayashi K; Nakano T; Kida A; Nakanishi T; Funatsu E; Noguchi C; Yoshihara S; Kaku K; Hirota S
Pathol Res Pract; 2015 Dec; 211(12):1014-9. PubMed ID: 26376466
[TBL] [Abstract][Full Text] [Related]
44. The role of endobronchial ultrasound-guided fine needle aspiration in the diagnosis of pleural mesothelioma.
Ghigna MR; Crutu A; Florea V; Soummer-Feulliet S; Baldeyrou P
Cytopathology; 2016 Aug; 27(4):284-8. PubMed ID: 26315262
[TBL] [Abstract][Full Text] [Related]
45. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
[TBL] [Abstract][Full Text] [Related]
46. Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.
Tsuji S; Tsuura Y; Morohoshi T; Shinohara T; Oshita F; Yamada K; Kameda Y; Ohtsu T; Nakamura Y; Miyagi Y
Br J Cancer; 2010 Aug; 103(4):517-23. PubMed ID: 20628387
[TBL] [Abstract][Full Text] [Related]
47. Chylothorax: A Tangled Road to Definitive Diagnosis of Non-Hodgkin Lymphoma.
Krūmiņa A; Auziņa D; Legzdiņa A; Lejniece S
Am J Case Rep; 2023 Jul; 24():e939098. PubMed ID: 37424096
[TBL] [Abstract][Full Text] [Related]
48. Pathological and molecular biological approaches to early mesothelioma.
Tsujimura T; Torii I; Sato A; Song M; Fukuoka K; Hasegawa S; Nakano T
Int J Clin Oncol; 2012 Feb; 17(1):40-7. PubMed ID: 22237727
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic usefulness of endobronchial ultrasound-guided transbronchial needle aspiration in a case with malignant pleural mesothelioma.
Hamamoto J; Notsute D; Tokunaga K; Sasaki J; Kojima K; Saeki S; Tanaka R; Tanaka H; Kohrogi H
Intern Med; 2010; 49(5):423-6. PubMed ID: 20190476
[TBL] [Abstract][Full Text] [Related]
50. Recurrent Large Volume Malignant Pleural Effusion in a Patient With Renal Cell Carcinoma.
Hutchinson AH; Fakhouri EW; Raudales J
Cureus; 2021 Feb; 13(2):e13593. PubMed ID: 33815993
[TBL] [Abstract][Full Text] [Related]
51. Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report.
Minami K; Jimbo N; Tanaka Y; Hokka D; Miyamoto Y; Itoh T; Maniwa Y
Virchows Arch; 2020 Mar; 476(3):469-473. PubMed ID: 31667596
[TBL] [Abstract][Full Text] [Related]
52. Malignant pleural neoplasm with both differentiation of epithelioid mesothelioma and squamous-cell carcinoma, a rare phenomena.
Re A; Shersher D; Allen A; Schwarting R; Ren S
Diagn Cytopathol; 2021 Jun; 49(6):E234-E237. PubMed ID: 33347735
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions.
Önder S; Özogul E; Koksal D; Sarinc Ulasli S; Firat P; Emri S
Cytopathology; 2019 Nov; 30(6):592-600. PubMed ID: 31165505
[TBL] [Abstract][Full Text] [Related]
54. Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea.
Kim YK; Kim JS; Lee KW; Yi CA; Goo JM; Jung SH
Korean J Radiol; 2016; 17(4):545-53. PubMed ID: 27390546
[TBL] [Abstract][Full Text] [Related]
55. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.
McGregor SM; McElherne J; Minor A; Keller-Ramey J; Dunning R; Husain AN; Vigneswaran W; Fitzpatrick C; Krausz T
Hum Pathol; 2017 Feb; 60():86-94. PubMed ID: 27771374
[TBL] [Abstract][Full Text] [Related]
56. A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion.
Gu R; Jiang L; Duan T; Chen C; Wu S; Mu D
Onco Targets Ther; 2021; 14():4231-4237. PubMed ID: 34295165
[TBL] [Abstract][Full Text] [Related]
57. Malignant pleural mesothelioma presenting as a spontaneous pneumothorax.
Mitsui A; Saji H; Shimmyo T; Mochizuki A; Kurimoto N; Nakamura H
Respirol Case Rep; 2015 Mar; 3(1):9-12. PubMed ID: 25802741
[TBL] [Abstract][Full Text] [Related]
58. Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report.
Rhazari M; Moueqqit O; Gartini S; El Morabit S; Diani S; Aharmim M; Thouil A; Kouismi H; El Bourkadi JE
Cureus; 2022 Apr; 14(4):e24478. PubMed ID: 35637829
[TBL] [Abstract][Full Text] [Related]
59. Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man.
Ibnian AM; Khan OU; Chan R; Bangalore Lakshminarayana U; Kiran F; Abed S; Abbas R; Amir A; Al-Kofahi NK
Am J Case Rep; 2023 Oct; 24():e941263. PubMed ID: 37793939
[TBL] [Abstract][Full Text] [Related]
60. Rare cause of paradoxical worsening of pleural effusion in a patient with tuberculosis.
Duraikannan P; Saheer S; Balamugesh T; Christopher DJ
Lung India; 2017; 34(2):167-169. PubMed ID: 28360466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
